DrugDashboards

piperacillin sodium and tazobactam sodium

piperacillin sodium and tazobactam sodium · PIPERACILLIN SODIUM 3 g/15mL; TAZOBACTAM SODIUM .375 g/15mL · Injection, Powder, Lyophilized, For Solution · Mitim S.r.l.

NDC 22607-0056-02 · 16 CARTON in 1 BOX / 10 VIAL, SINGLE-USE in 1 CARTON / 15 mL in 1 VIAL, SINGLE-USE · DRUG FOR FURTHER PROCESSING · View full market →

Bulk ingredient — not a finished product

This NDC is a raw material (drug for further processing) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.

Medicare Part D

This is a bulk ingredient, not a dispensable product — it is a raw material sold to manufacturers and compounders, so no plan prices it.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.5%chance of a new FDA shortage posting for piperacillin sodium and tazobactam sodium (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 4× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
TE code
Approval date
Patents / exclusivity

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of piperacillin sodium and tazobactam sodium (Injection, Powder, Lyophilized, For Solution)

LabelerStrengthFirst seenLast seen
Eugia US LLCPIPERACILLIN SODIUM 4 g/1; TAZOBACTAM SODIUM .5 g/1Jul 15, 2026Sep 3, 2026
Eugia US LLCPIPERACILLIN SODIUM 2 g/1; TAZOBACTAM SODIUM .25 g/1Jul 15, 2026Sep 3, 2026
Eugia US LLCPIPERACILLIN SODIUM 36 g/250mL; TAZOBACTAM SODIUM 4.5 g/250mLJul 15, 2026Sep 2, 2026
Eugia US LLCPIPERACILLIN SODIUM 12 g/100mL; TAZOBACTAM SODIUM 1.5 g/100mLJul 15, 2026Sep 2, 2026
Mitim S.r.l.PIPERACILLIN SODIUM 3 g/15mL; TAZOBACTAM SODIUM .375 g/15mLJul 15, 2026Sep 2, 2026
Mitim S.r.l.PIPERACILLIN SODIUM 4 g/20mL; TAZOBACTAM SODIUM .5 g/20mLJul 15, 2026Sep 2, 2026
Mitim S.r.l.PIPERACILLIN SODIUM 2 g/10mL; TAZOBACTAM SODIUM .25 g/10mLJul 15, 2026Sep 2, 2026
Provepharm Inc.PIPERACILLIN SODIUM 4 g/20mL; TAZOBACTAM SODIUM .5 g/20mLJul 15, 2026Sep 2, 2026
Provepharm Inc.PIPERACILLIN SODIUM 12 g/60mL; TAZOBACTAM SODIUM 1.5 g/60mLJul 15, 2026Sep 2, 2026
Provepharm Inc.PIPERACILLIN SODIUM 2 g/10mL; TAZOBACTAM SODIUM .25 g/10mLJul 15, 2026Sep 2, 2026
Provepharm Inc.PIPERACILLIN SODIUM 3 g/15mL; TAZOBACTAM SODIUM .375 g/15mLJul 15, 2026Sep 2, 2026
Provepharm Inc.PIPERACILLIN SODIUM 36 g/180mL; TAZOBACTAM SODIUM 4.5 g/180mLJul 15, 2026Sep 2, 2026
Eugia US LLCPIPERACILLIN SODIUM 3 g/1; TAZOBACTAM SODIUM .375 g/1Jul 15, 2026Aug 31, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "piperacillin sodium and tazobactam sodium — NDC 22607-0056-02," retrieved September 3, 2026, https://drugdashboards.com/drug/22607005602.

Free to cite with attribution — see how the data is put together.